Skip to content
BTI

British American Tobacco p.l.c.

British American Tobacco p.l.c. Q4 FY2023 earnings call

February 8, 2024 · fiscal period ended 2023-12

EPS · actual vs est

$-10.39 / $2.49Miss -517.1%

Revenue · actual vs est

$17.50B / $18.85BMiss -7.2%
Ask about this call

Summary

Generated 2024-02-08

Management highlights

Management Statement and Operational Highlights

  • New Category Profitability: Reached new category profitability two years ahead of target, with £300M incremental investment in 2023. New categories meaningfully contributing to group results with profitability gains.
  • U.S. Combustibles: Commercial plans delivering early volume and value share recovery in premium segments, with Newport and Natural American Spirit showing gains.
  • Heated Products: Global patent settlement enables innovation. Launched glo Hyper pro and veo, strengthening innovation pipeline.
  • Responsible Development: Re-established corporate and regulatory affairs function, engaging with regulators on differentiated regulation of smokeless products.
  • Financial Flexibility: On track to save £1B by 2025, with £500M saved in 2023. Evaluating stake in ITC for capital reallocation; exited 35 non-strategic markets.
  • Culture: Refreshed corporate values, new senior management members, including incoming CFO.
View in transcript ↓

Segment performance

Segment Performance

  • New Categories: Organic revenue growth of 21%, with Vuse and Velo driving volume-led growth. Reached new category profitability two years ahead of target, with top 10 new category markets generating ~three quarters of new category revenue in 2023 and category contribution margin above 20%.
  • Combustibles: Cigarette volume declined 5.3% organically. AME had 13% organic revenue growth driven by Combustibles and New Categories. U.S. Combustibles faced macro pressures but showed early volume and value share recovery in premium segments.
  • Heated Products: glo revenue down 2.5% but up 4.1% organically. Launched glo Hyper pro and veo, with veo showing promising results in some European markets.
  • Modern Oral: Volume up 33.6%, revenue up 39%. Velo pilot in NY positive, strong in most markets except U.S. with growth in emerging markets like Pakistan and Kenya.
View in transcript ↓

Guidance

Guidance

  • 2024: Expect low-single digit organic revenue and adjusted profit from operations growth, including 2% transactional FX headwind. Second half weighted by macro pressures and illicit vapes in U.S.
  • Long-Term: Aim to be a predominantly smokeless business with 50% smokeless revenue by 2035, smokeless revenue to reach ~1/3 of group revenue by 2030.
View in transcript ↓

Risks

Risks

  • U.S. Market: Macro-economic pressures, growth of illicit single-use vapes, uncertainty around menthol ban impacting U.S. Combustibles.
  • Regulatory: Varied regulation of smokeless products, potential underage access and environmental impacts if not managed responsibly.
  • ITC Stake: Complexity in regulatory process to reduce stake in ITC, uncertainty around timeline and use of proceeds.
View in transcript ↓

Q&A highlights

Question and Answer

  • Q: U.S. Vapour category growth and U.S. Combustibles normalized volume declines A: Vapour growing substantially, ~29M users, 20%+ growth. U.S. Combustibles volume decline expected to stabilize around 5%-6% post-macro normalization, dependent on enforcement of illicit products.
  • Q: ITC stake approvals and heated tobacco EU flavour ban A: Working on regulatory process for ITC stake, unclear timeline but aim to reallocate capital. EU flavour ban impacted Heated Products, but BAT retained/share grew in markets like Czech Republic with veo.
  • Q: Newport pricing, new product launches, leverage A: Newport pricing measured, positive early signs. New products in Modern Oral and Vapour, with strong pipeline. Leverage target mid-2x to 3x, focus on cash generation for flexibility.
  • Q: glo Hyper Pro pricing, vaping market formalization A: glo Hyper Pro improved, pricing dependent on competitive landscape. Expecting more markets to formalize vaping regulation, supporting Tobacco Harm Reduction, with countries like New Zealand, U.K., Canada showing progress.
View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-10.39$2.49-517.1%$1.28
Revenue$17.50B$18.85B-7.2%$18.17B

Transcript

February 8, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.